ArticleDiscover oncology2025

Adenylosuccinate lyase (ADSL) is a pan-cancer prognostic and immune biomarker with distinct roles in hepatocellular carcinoma.

Weixiong Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.